Osteopenia Completed Phase 4 Trials for L-Arginine (DB00125)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01222026Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium RanelateTreatment